Partnering to champion policies that drive the discovery, development and delivery of transformative medicines and vaccines.
Ottawa, November 5, 2026—Innovative Medicines Canada (IMC) welcomes the federal government’s recognition of the pharmaceutical and life sciences sector in […]
Ottawa, October 19, 2026 – Innovative Medicines Canada (IMC) welcomes the press release issued by provincial and territorial (PT) health […]
By Dr. Bettina Hamelin One year ago, the Ontario government made a decision: Patients shouldn’t have to wait up to […]
Medicine Matters Canada is a new national public advocacy platform dedicated to improving patient access to innovative medicines and strengthening Canada’s life sciences sector.
The Health Research Foundation (HRF) is a non-profit organization that invests in Canadian applied health systems research and that contributes to the sustainability of the Canadian healthcare system for improved patient outcomes.
New medicines aren’t always available through public drug plans when Canadian patients need them. After Health Canada approves a new medicine as safe and effective, Canadians still wait an average of two years for access. These delays have existed for many years, yet little progress was made in 2025, with the notable exception of the Ontario government’s Funding Accelerated for Specific Treatments (FAST) Program.
Total yearly economic impact
Invested annually in research and development
High-quality Canadian jobs
Our 40+ member companies are leaders in life sciences and pharmaceutical innovation.
Stay informed with timely, relevant content on key issues shaping our industry.
